Developing countries are turning to each other for affordable and targeted solutions to national health problems, a study of South–South biotechnology collaborations has found.
'Brother–sister' trade relationships between developing countries allow cheaper drugs and vaccines to reach more poor people than do 'parent–child' relationships with the developed world, according to a study published in Nature Biotechnology (May 10).
The study was a collaboration between researchers from Canada and five developing countries who interviewed 300 biotech company staff from 13 nations. The researchers said it was the lack of information about such collaborations that prompted the study.